Patents Represented by Attorney Amylin Pharmaceuticals, LLC

Find this attorney in the Justia Lawyer Directory

  • Use of leptin to treat metabolic abnormalities associated with lipoatrophy
    Patent number: 8318666
    Abstract: Leptin, leptin analogs, and leptin derivatives are used to treat patients with lipoatrophy. Leptin is effective against conditions of lipoatrophy for both genetic and acquired forms of the disease. A therapeutically effective amount of leptin can be administered in a variety of ways, including subcutaneously and using gene therapy methods. Methods of the present invention contemplate administration of leptin, leptin analogs, and leptin derivatives to patients having a leptin level of approximately 4 ng/ml or less before treatment.
    Type: Grant
    Filed: May 9, 2011
    Date of Patent: November 27, 2012
    Assignees: Amgen, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services, Board of Regents, The University of Texas System
    Inventors: Alexander M. DePaoli, Elif Arioglu Oral, Simeon I. Taylor, Abhimanyu Garg
  • Neuromedin and FN-38 peptides for treating psychiatric diseases
    Patent number: 8309522
    Abstract: Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an NMX peptide, an FNX peptide, or an NMX receptor agonist, or analogs or derivatives thereof, to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.
    Type: Grant
    Filed: February 4, 2008
    Date of Patent: November 13, 2012
    Assignee: Amylin Pharmaceuticals, LLC
    Inventors: Kevin D. Laugero, Michael R. Hanley, Christine M. Mack, David G. Parkes, Paul McGonigle
  • Method of modifying food preference comprising administering amylin or amylin agonist
    Patent number: 8278267
    Abstract: Compositions and methods for preventing, treating or controlling conditions or disorders associated with obesity, diet and nutrition are provided. The methods provided generally involve the administration of an Amylin or an Amylin agonist to a subject in order to prevent, treat or control conditions or disorders associated with obesity, diet and nutrition.
    Type: Grant
    Filed: December 9, 2010
    Date of Patent: October 2, 2012
    Assignee: Amylin Pharmaceuticals, LLC
    Inventors: Christian Weyer, Kevin D. Laugero, Christine M. Mack, David G. Parkes